Synaptic proteins in CSF relate to Parkinson’s disease stage markers
Biomarkers: Synaptic proteins give it away The levels of synaptic proteins in the cerebrospinal fluid (CSF) correlate with Parkinson’s disease (PD) severity. Dysfunctional communication between nerve cells is an established hallmark of early stage PD and other neurodegenerative disorders. As synapse...
Guardado en:
Autores principales: | Erika Bereczki, Anna Bogstedt, Kina Höglund, Panagiota Tsitsi, Lovisa Brodin, Clive Ballard, Per Svenningsson, Dag Aarsland |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/388e5cf2ffc74b24ba90cf4aac03e2f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer’s disease at various cognitive stages
por: Odile Poirel, et al.
Publicado: (2018) -
A non-invasive olfactory bulb measure dissociates Parkinson’s patients from healthy controls and discloses disease duration
por: Behzad Iravani, et al.
Publicado: (2021) -
Synaptic potentiation of anterior cingulate cortex contributes to chronic pain of Parkinson’s disease
por: Zhaoxiang Zhou, et al.
Publicado: (2021) -
Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari S, et al.
Publicado: (2017) -
CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.
por: Patrick Oeckl, et al.
Publicado: (2012)